北京大学学报(医学版)
北京大學學報(醫學版)
북경대학학보(의학판)
JOURNAL OF BEIJING MEDICAL UNIVERSITY(HEALTH SCIENCES)
2011年
2期
213-221
,共9页
周庆涛%贺蓓%姚贝%刘振英%张捷
週慶濤%賀蓓%姚貝%劉振英%張捷
주경도%하배%요패%류진영%장첩
鲍曼不动杆菌%药物疗法,联合%抗药性%交叉感染%电泳,凝胶,脉冲场
鮑曼不動桿菌%藥物療法,聯閤%抗藥性%交扠感染%電泳,凝膠,脈遲場
포만불동간균%약물요법,연합%항약성%교차감염%전영,응효,맥충장
Acinetobacter baumannii%Drug therapy,combination%Drug resistance%Cross infection%Electrophoresis,gel,pulsed-field
目的:分析2007年1月至2008年3月北京大学第三医院临床分离的耐碳青霉烯鲍曼不动杆菌的同源性,调查其定植或感染的危险因素,评价该菌所致医疗相关性感染的抗菌药物治疗.方法:通过复习病历收集耐碳青霉烯鲍曼不动杆菌定植或感染患者的临床资料.菌株的药敏试验采用纸片法,通过脉冲场凝胶电泳分析菌株的同源性.结果:研究期间共分离到49株耐碳青霉烯鲍曼不动杆菌菌株,其脉冲场凝胶电泳分型为7型,共45株(91.8%)具有同源性.分离到菌株前患者最常见的暴露因素为住ICU、侵入性操作和低白蛋白血症,最常见的合并症是慢性阻塞性肺疾病(12例)和脑血管病(10例).在这49株菌中,定植者28株,导致感染者21株,感染患者的死亡率为38.1%.Logistic回归分析发现APACHEⅡ评分是导致死亡的独立危险因素(P=0.02,OR=1.7,95%CI1.1~2.5).抗菌药物联合治疗的成功率高于单药治疗(11/13例,84.6%vs.3/17例,17.6%),尤其是头孢哌酮/舒巴坦联合左氧氟沙星联合治疗.结论:我院自2007年出现了耐碳青霉烯鲍曼不动杆菌菌株的院内播散,导致播散的危险因素为住ICU、侵入性操作、低白蛋白血症、慢性阻塞性肺疾病和脑血管病,对耐碳青霉烯鲍曼不动杆菌感染,抗菌药物联合治疗可能优于单药治疗.
目的:分析2007年1月至2008年3月北京大學第三醫院臨床分離的耐碳青黴烯鮑曼不動桿菌的同源性,調查其定植或感染的危險因素,評價該菌所緻醫療相關性感染的抗菌藥物治療.方法:通過複習病歷收集耐碳青黴烯鮑曼不動桿菌定植或感染患者的臨床資料.菌株的藥敏試驗採用紙片法,通過脈遲場凝膠電泳分析菌株的同源性.結果:研究期間共分離到49株耐碳青黴烯鮑曼不動桿菌菌株,其脈遲場凝膠電泳分型為7型,共45株(91.8%)具有同源性.分離到菌株前患者最常見的暴露因素為住ICU、侵入性操作和低白蛋白血癥,最常見的閤併癥是慢性阻塞性肺疾病(12例)和腦血管病(10例).在這49株菌中,定植者28株,導緻感染者21株,感染患者的死亡率為38.1%.Logistic迴歸分析髮現APACHEⅡ評分是導緻死亡的獨立危險因素(P=0.02,OR=1.7,95%CI1.1~2.5).抗菌藥物聯閤治療的成功率高于單藥治療(11/13例,84.6%vs.3/17例,17.6%),尤其是頭孢哌酮/舒巴坦聯閤左氧氟沙星聯閤治療.結論:我院自2007年齣現瞭耐碳青黴烯鮑曼不動桿菌菌株的院內播散,導緻播散的危險因素為住ICU、侵入性操作、低白蛋白血癥、慢性阻塞性肺疾病和腦血管病,對耐碳青黴烯鮑曼不動桿菌感染,抗菌藥物聯閤治療可能優于單藥治療.
목적:분석2007년1월지2008년3월북경대학제삼의원림상분리적내탄청매희포만불동간균적동원성,조사기정식혹감염적위험인소,평개해균소치의료상관성감염적항균약물치료.방법:통과복습병력수집내탄청매희포만불동간균정식혹감염환자적림상자료.균주적약민시험채용지편법,통과맥충장응효전영분석균주적동원성.결과:연구기간공분리도49주내탄청매희포만불동간균균주,기맥충장응효전영분형위7형,공45주(91.8%)구유동원성.분리도균주전환자최상견적폭로인소위주ICU、침입성조작화저백단백혈증,최상견적합병증시만성조새성폐질병(12례)화뇌혈관병(10례).재저49주균중,정식자28주,도치감염자21주,감염환자적사망솔위38.1%.Logistic회귀분석발현APACHEⅡ평분시도치사망적독립위험인소(P=0.02,OR=1.7,95%CI1.1~2.5).항균약물연합치료적성공솔고우단약치료(11/13례,84.6%vs.3/17례,17.6%),우기시두포고동/서파탄연합좌양불사성연합치료.결론:아원자2007년출현료내탄청매희포만불동간균균주적원내파산,도치파산적위험인소위주ICU、침입성조작、저백단백혈증、만성조새성폐질병화뇌혈관병,대내탄청매희포만불동간균감염,항균약물연합치료가능우우단약치료.
Objective:To assess the genetic relationship of clinical isolates of carbapenem-resistant A.baumannii (resistant to both imipenem and meropenem) from January 2007 to March 2008 in Peking University Third Hospital for measures to decrease the isolates; to investigate the characteristics of patients with carbapenem-resistant A. baumannii colonization or infection and to evaluate antibiotic treatment for health care-associated infections caused by carbapenem-resistant A. baumannii. Methods: The medical records of patients with carbapenem-resistant A. baumannii colonization or infection were reviewed. Antibiotic susceptibilities of the isolates were determined by the standardized disk-diffusion method and the clonal relationship of the isolates was analyzed by pulsed-field gel electrophoresis. Results: A total of 49 carbapenem-resistant A. baumannii strains were isolated from the 49 patients hospitalized during the study period and pulsed-field gel electrophoresis typing yielded 7 different patterns. A total of 45 (91.8%)genotyped strains showed clonal relationship. The most frequently identified predisposing factors were intensive care unit stay, invasive procedures, and hypoalbuminemia. Chronic obstructive pulmonary disease (12 cases) and cerebrovascular disease (10 cases) were the most common comorbid conditions.The mortality of patients with carbapenem-resistant A. baumannii infection was 38. 1% (8 of 21 patients), and the acute physiology and chronic health evaluation Ⅱ score, initial antibiotic therapy failure rate and the presence of hypoalbuminemia were significantly increased in the death group. Combination therapy regimens had higher success rates than monotherapy regimens (11/13, 84. 6% vs. 3/17,17.6%). Conclusion: There has been clonal spread of carbapenem-resistant A. baumannii strains among patients in our hospital since 2007. Intensive care unit stay, invasive procedures, hypoalbuminemia, chronic obstructive pulmonary disease and cerebrovascular disease were common in patients with carbapenem-resistant A. baumannii colonization or infection. Antibiotic combination therapy may be effective for carbapenem-resistant A. baumannii infection.